AstraZeneca PLC revenue for the last year amounted to 41.51 B EUR, the most of which — 15.91 B EUR — came from its highest performing source at the moment, Oncology, the year earlier bringing 13.42 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought AstraZeneca PLC 16.81 B EUR, and the year before that — 15.85 B EUR.